The Viral “Tripledemic” Opportunity
January 14, 2023 at 08:36 AM EST
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu medicines. Let’s take a look.
